a public good project by the
Synthesis
Company
of California

© 2026

Mathias Nettekoven | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Mathias Nettekoven

Roche (Switzerland)(CH)

Research Areas

Bipolar Disorder and Treatment, Phosphodiesterase function and regulation, Amino Acid Enzymes and Metabolism

Most-Cited Works

→ Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia(2010)134 cited